Search
for

    Glossary Alefacept

    biologic drug that targets T-cells in autoimmune conditions

    Alefacept is a biologic medication that was used to treat moderate to severe plaque psoriasis, an autoimmune skin condition. It works by targeting and reducing the activity of specific immune cells (T-cells) that are involved in the inflammatory process of psoriasis. Although it was effective for some patients, it has been discontinued in many markets due to the availability of newer treatments.

    Research 10 of 91

    1. Treatment of Generalized Lichen Planus With Alefacept Archives of Dermatology · 2006 · 52 citations
    2. Alefacept for Severe Alopecia Areata Archives of dermatology · 2009 · 43 citations
    3. Alefacept for Alopecia Areata Archives of dermatology · 2005 · 33 citations
    4. Alefacept for Severe Alopecia Areata: A Randomized, Double-blind, Placebo-Controlled Study Yearbook of Dermatology and Dermatologic Surgery · 2011 · 3 citations
    5. Systemic treatments for alopecia areata: A systematic review Australasian journal of dermatology · 2018 · 41 citations
    6. Novel therapies for alopecia areata: The era of rational drug development The Journal of Allergy and Clinical Immunology · 2017 · 9 citations
    7. Cytokine-targeted treatment in alopecia areata - new possibilities? Prospects in Pharmaceutical Sciences · 2023 · 1 citations
    8. Dermatological drugs, topical agents, and cosmetics Side effects of drugs annual · 2005 · 1 citations
    9. Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine Skin Appendage Disorders · 2025
    10. 12. Cancer Journal of Cutaneous Medicine and Surgery · 2003
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →